Physical Disability Observational Study in Patients Treated With Betaferon in Daily Practice.

Trial Profile

Physical Disability Observational Study in Patients Treated With Betaferon in Daily Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2013

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 10 Nov 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 10 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Jul 2011 Planned end date changed from 1 Jul 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top